Technical Analysis for ZYME - Zymeworks Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
BB Squeeze Ended | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 1.67% | |
Bollinger Band Squeeze | Range Contraction | 1.67% | |
BB Squeeze + Upper Band Touch | Range Contraction | 1.67% | |
Gapped Up | Strength | 1.67% |
Alert | Time |
---|---|
10 DMA Resistance | about 18 hours ago |
Possible Inside Day | about 18 hours ago |
10 DMA Support | about 21 hours ago |
60 Minute Opening Range Breakdown | about 21 hours ago |
Gap Up Partially Closed | about 22 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/02/2024
Zymeworks Inc. Description
Zymeworks Inc is a Canada-based clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of multifunctional biotherapeutics. The Company's ZymeCAD platform is for protein modeling and structure-guided protein engineering. The Company's platforms include Azymetric Platform, AlbuCORE Platform, EFECT Platform and Zymelink Conjugation Platform + Cytotoxins. The Company's lead product candidate, ZW25, is a bispecific antibody, which is being evaluated in an adaptive Phase I clinical trial. Its ZW33 is a bi-specific antibody that delivers a cytotoxic payload to cancers cells by binding to different epitopes (bi-paratopic targeting) of the overexpressed HER2 protein. It focuses on developing a pipeline of preclinical product candidates and discovery-stage programs in immuno-oncology and other therapeutic areas. It analyzes protein characteristics to develop the scope of protein engineering to tackle biological systems.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Immunology Immune System Cancer Immunotherapy Monoclonal Antibodies Antibody Toxins Glycoproteins Her2 Protein Engineering Biological Systems Bispecific Monoclonal Antibody
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.14 |
52 Week Low | 6.015 |
Average Volume | 465,135 |
200-Day Moving Average | 8.92 |
50-Day Moving Average | 9.64 |
20-Day Moving Average | 8.81 |
10-Day Moving Average | 9.09 |
Average True Range | 0.48 |
RSI (14) | 50.25 |
ADX | 24.33 |
+DI | 14.65 |
-DI | 15.28 |
Chandelier Exit (Long, 3 ATRs) | 8.17 |
Chandelier Exit (Short, 3 ATRs) | 9.42 |
Upper Bollinger Bands | 9.47 |
Lower Bollinger Band | 8.16 |
Percent B (%b) | 0.76 |
BandWidth | 14.92 |
MACD Line | -0.11 |
MACD Signal Line | -0.22 |
MACD Histogram | 0.1073 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.97 | ||||
Resistance 3 (R3) | 10.02 | 9.79 | 9.83 | ||
Resistance 2 (R2) | 9.79 | 9.58 | 9.77 | 9.79 | |
Resistance 1 (R1) | 9.47 | 9.45 | 9.36 | 9.42 | 9.74 |
Pivot Point | 9.25 | 9.25 | 9.19 | 9.22 | 9.25 |
Support 1 (S1) | 8.93 | 9.04 | 8.81 | 8.88 | 8.56 |
Support 2 (S2) | 8.70 | 8.91 | 8.68 | 8.51 | |
Support 3 (S3) | 8.38 | 8.70 | 8.47 | ||
Support 4 (S4) | 8.33 |